Klotho's Impact on Cardiovascular Disease, Fractures, and Mortality in Hemodialysis

Akio Nakashima1, Kazuhiko Kato1, Arisa Kobayashi1

  • 1Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.

PubMed

Insights

Low levels of soluble Klotho (sKlotho), an aging-suppressor protein, are linked to increased cardiovascular disease, fractures, and mortality in hemodialysis patients. This highlights sKlotho

Area of Science:

  • Nephrology and Gerontology
  • Biomarker Discovery
  • Cardiovascular and Skeletal Health

Background:

  • Klotho, an aging-suppressor protein, shows promise in animal models for improving cardiovascular and bone health in chronic kidney disease (CKD).
  • Clinical data on the role of soluble Klotho (sKlotho) in hemodialysis patients' outcomes remain limited.
  • Understanding sKlotho's association with clinical events is crucial for risk stratification in this population.

Purpose of the Study:

  • To investigate the association between serum sKlotho levels and cardiovascular disease (CVD) events.
  • To examine the relationship between sKlotho and fracture incidence.
  • To assess the link between sKlotho and all-cause mortality in patients undergoing hemodialysis.

Main Methods:

  • A cohort of 1241 hemodialysis patients was recruited from multiple institutions.
  • Patients were followed for a median of 39 months.
  • The primary composite outcome included CVD events, fractures, and all-cause mortality.

Main Results:

  • The median sKlotho concentration was 325.6 pg/ml.
  • Patients in the lowest quartile of sKlotho exhibited significantly higher risks for CVD events (HR=1.76), fractures (HR=1.99), and mortality (HR=1.74) compared to the highest quartile.
  • 436 CVD events, 100 fractures, and 228 deaths were recorded during follow-up.

Conclusions:

  • Low serum sKlotho levels are strongly associated with adverse cardiovascular and skeletal outcomes in hemodialysis patients.
  • Reduced sKlotho is a significant predictor of increased all-cause mortality in this population.
  • sKlotho may serve as a valuable biomarker for risk stratification among high-risk hemodialysis patients.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
543
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
628
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
730
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
333
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.3K